Study finds promising results for treatment of depression in people who haven’t responded to standard antidepressants ...

Federal regulators fast-tracked approval of psychedelic drugs to treat some of the nation’s most stubborn mental health disorders, reopening a debate that has lingered since the counterculture era: ...

Modern psychiatry has long struggled with one brutal fact: the people most at risk of suicide often cannot wait weeks for ...

This story was reviewed by Daniel Z. Lieberman, MD. Maybe you’re neck-deep in a two-week funk you just can’t seem to shake, or perhaps you’ve been struggling with severe depression for years. No ...

Depression is one of the most widespread health conditions in the world. According to the World Health Organization, it affects more than 280 million people globally, cutting across age, gender, and ...

The anti-inflammatory drug tocilizumab targets the IL-6 pathway to achieve a 54% remission rate in hard-to-treat depression.

Researchers report substantial decreases in depression symptoms by tailoring behavioral interventions based on data ...

When new patients come to see me, they typically complain about a wide range of symptoms—they’re not sleeping well, can’t concentrate, are irritable with their spouse, children, and/or colleagues, ...

A single dose of psilocybin eased symptoms of depression within days, with benefits lasting for more than three months compared to placebo, our new study has found.

Depression treatment often takes weeks to months to show full effects, so recognizing when adjustments are needed means noting persistent symptoms that disrupt daily life despite adequate time on ...

A pair of smart glasses managed to reduce symptoms of depression by sending signals to the brain through the eye.